tetano
Editor, Senior Moderator
Bull Natl Res Cent
. 2021;45(1):79.
doi: 10.1186/s42269-021-00540-y. Epub 2021 Apr 23.
Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity
Ramakrishnan Veerabathiran[SUP] 1 [/SUP], Barath Ragunath[SUP] 1 [/SUP], Vaishak Kaviarasan[SUP] 1 [/SUP], Vajagathali Mohammed[SUP] 1 [/SUP], Shiek S S J Ahmed[SUP] 2 [/SUP]
Affiliations
Abstract
Background: The ongoing pandemic of COVID-19 viruses takes its sole origin from the Wuhan Huanan seafood market, China. The first case was recorded as viral pneumonia and later became a worldwide pandemic (officially declared by WHO on March 11, 2020).
Main body: SARS-CoV-2 is an extremely infectious and transferrable virus that develops severe conditions like respiratory syndrome, high blood pressure and weakens the immune system. Coronavirus falls under the Coronaviridae family and Beta coronavirus genus. Affected individuals will encounter problems starting with fever followed by severe complications like SARS, ARDS, and many others. These SARS-CoV and MERS-CoV enter the host cells by the endosomal pathway, and about 16 non-structural proteins are involved in assembling the viral RNA synthesis complex. They possess a positive-sense single-stranded RNA, and about four major genes are mainly associated with the development of ASRD, SARS, and other respiratory problems.
Conclusion: Susceptibility of these four major genes such as ACE2, IL-2, 7 and 10, TNF, and VEGF is associated with COVID-19. This highlights the identification of the above-mentioned genes that can be used as potential biomarkers for early diagnosis and targeted drug delivery for treating the SARS-CoV-2 neurological symptoms and reducing inflammation in the brain.
Keywords: ACE2; Cytokines; Genes; Interleukin; SARS-CoV-2.
. 2021;45(1):79.
doi: 10.1186/s42269-021-00540-y. Epub 2021 Apr 23.
Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity
Ramakrishnan Veerabathiran[SUP] 1 [/SUP], Barath Ragunath[SUP] 1 [/SUP], Vaishak Kaviarasan[SUP] 1 [/SUP], Vajagathali Mohammed[SUP] 1 [/SUP], Shiek S S J Ahmed[SUP] 2 [/SUP]
Affiliations
- PMID: 33907373
- PMCID: PMC8063172
- DOI: 10.1186/s42269-021-00540-y
Abstract
Background: The ongoing pandemic of COVID-19 viruses takes its sole origin from the Wuhan Huanan seafood market, China. The first case was recorded as viral pneumonia and later became a worldwide pandemic (officially declared by WHO on March 11, 2020).
Main body: SARS-CoV-2 is an extremely infectious and transferrable virus that develops severe conditions like respiratory syndrome, high blood pressure and weakens the immune system. Coronavirus falls under the Coronaviridae family and Beta coronavirus genus. Affected individuals will encounter problems starting with fever followed by severe complications like SARS, ARDS, and many others. These SARS-CoV and MERS-CoV enter the host cells by the endosomal pathway, and about 16 non-structural proteins are involved in assembling the viral RNA synthesis complex. They possess a positive-sense single-stranded RNA, and about four major genes are mainly associated with the development of ASRD, SARS, and other respiratory problems.
Conclusion: Susceptibility of these four major genes such as ACE2, IL-2, 7 and 10, TNF, and VEGF is associated with COVID-19. This highlights the identification of the above-mentioned genes that can be used as potential biomarkers for early diagnosis and targeted drug delivery for treating the SARS-CoV-2 neurological symptoms and reducing inflammation in the brain.
Keywords: ACE2; Cytokines; Genes; Interleukin; SARS-CoV-2.